PhD candidate Deepa Nakmode and her supervisor Professor Sanjay Garg worked for over two years to develop a once-a-week injection that steadily feeds Parkinson’s drugs into the bloodstream, aiming for smoother symptom control and far fewer pills. Credit: Supplied
Researchers at the University of South Australia have developed a long-acting injectable formulation that provides a consistent dose of levodopa and carbidopa—two essential Parkinson’s medications—over the course of a week. SBS Hindi spoke with lead researcher Professor Sanjay Garg about how the two-year old study which could represent a breakthrough for those affected by Parkinson’s. Parkinson’s Australia, the leading advocacy organisation, reports that more than 150,000 Australians are living with Parkinson’s disease.
Researchers at the University of South Australia have developed a long-acting injectable formulation that provides a consistent dose of levodopa and carbidopa—two essential Parkinson’s medications—over the course of a week. SBS Hindi spoke with lead researcher Professor Sanjay Garg about how the two-year old study which could represent a breakthrough for those affected by Parkinson’s. Parkinson’s Australia, the leading advocacy organisation, reports that more than 150,000 Australians are living with Parkinson’s disease.
Disclaimer: This information is intended as a general guide. For advice tailored to your situation, please consult a qualified professional.
